pharma’s
- Business
Huge pharma’s blockbuster obesity drug battle is correct getting started, and or now not it’s headed for $100 billion
Ozempic drug to treat diabetes. Courtesy: Ozempic In their most new earnings reports, Novo Nordisk and Eli Lilly proved why…
Read More » - Business
Supreme Court docket blocks Purdue Pharma’s broad opioid settlement, will hear verbalize
CNBC Politics The Supreme Court docket on Thursday blocked, for now, a multi-billion-buck chapter settlement by Purdue Pharma that would…
Read More »